If payment for organs drives up the financial costs of transplants compared to the costs of dialysis, is it possible that private insurance companies, and even Medicare and Medicaid, might respond by changing their standards for transplants? Could the standards change in different directions (tighter for one, looser for the other)? If the standards were to change, who would gain and who would lose compared to the current system?